Literature DB >> 2482955

[Acute phase proteins as markers of septic risk in surgical patients].

E Pompilio, R Casigliani, S Sommariva, M P Saggese.   

Abstract

A heterogeneous group of surgery patients at septic risk was studied through monitoring of acute phase proteins (APP). Plasma levels of 8 acute phase proteins (C-reactive, alpha-1 antitrypsin, fibrinogen, ceruloplasmin, transferrin, albumin, prealbumin, alpha-2 macroglobulin) were measured in the pre- and postoperative period of septic surgery patients suffering from disease processes in various sites and with different aetiopathogenesis. The experiment is related to some interesting research proposed by authors in the Shock Physiopathology Study Centre of the Catholic University of Rome and their results. The constant finding of increased values of PCR, fibrin, cerul, alpha-1 Tryp in the septic risk surgery patient and their normalisation following treatment is particularly significant. In these same cases, a depression or, depending on circumstances, normal findings of Transf, alpha-2 Macro, Albu and Prealbu were observed. The results point to the practical utility an high reliability of APP changes as markers of septic risk.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482955

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  2 in total

1.  Procalcitonin and C-reactive protein as early markers of anastomotic leak after laparoscopic colorectal surgery within an enhanced recovery after surgery (ERAS) program.

Authors:  José Luis Muñoz; María Oliva Alvarez; Vicent Cuquerella; Elena Miranda; Carlos Picó; Raquel Flores; Marta Resalt-Pereira; Pedro Moya; Ana Pérez; Antonio Arroyo
Journal:  Surg Endosc       Date:  2018-03-08       Impact factor: 4.584

2.  C-reactive protein, fibrinogen, and procalcitonin levels as early markers of staple line leak after laparoscopic sleeve gastrectomy in morbidly obese patients within an Enhanced Recovery After Surgery (ERAS) program.

Authors:  Jaime Ruiz-Tovar; Jose Luis Muñoz; Juan Gonzalez; Alejandro Garcia; Carlos Ferrigni; Montiel Jimenez; Manuel Duran
Journal:  Surg Endosc       Date:  2017-06-07       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.